blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2155680

EP2155680 - INDANONE DERIVATIVES THAT INHIBIT PROLYL HYDROXYLASE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.10.2014
Database last updated on 19.10.2024
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): TR		published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
Amgen, Inc
Patent Operations, M/S 28-2-C One Amgen Center Drive
Thousand Oaks, California 91320-1799 / US
[2010/08]
Inventor(s)01 / ALLEN, Jennifer R.
5255 Via Capote
Newbury Park, California 91320 / US
02 / BURLI, Roland
9 Crescent Road
Bishop's Shortford
Hertfordshire, CM23 5JT / GB
03 / GOLDEN, Jennifer E.
23925 W. 124th Court
Olathe, KS 66061 / US
04 / MULLER, Kristine M.
3190 Oak Road, Nr. 216
Walnut Creek, CA 94597 / US
05 / REED, Anthony B.
3101 Peninsula Road, Apt. 304
Oxnard, California 93035 / US
 [2013/49]
Former [2010/08]01 / ALLEN, Jennifer R.
5255 Via Capote
Newbury Park, California 91320 / US
02 / BURLI, Roland
9 Crescent Road Bishop's Shortford
Hertfordshire, CM23 5JT / GB
03 / GOLDEN, Jennifer E.
23925 W. 124th Court
Olathe, KS 66061 / US
04 / MULLER, Kristine M.
3190 Oak Road, Nr. 216
Walnut Creek, CA 94597 / US
05 / REED, Anthony B.
3101 Peninsula Road, Apt. 304
Oxnard, California 93035 / US
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstrasse 4
80802 München / DE
[N/P]
Former [2013/49]Grünecker, Kinkeldey, Stockmair & Schwanhäusser
Leopoldstrasse 4
80802 München / DE
Former [2010/08]Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
Leopoldstrasse 4
80802 München / DE
Application number, filing date08742727.409.04.2008
[2010/08]
WO2008US04634
Priority number, dateUS20070925318P18.04.2007         Original published format: US 925318 P
[2010/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008130508
Date:30.10.2008
Language:EN
[2008/44]
Type: A1 Application with search report 
No.:EP2155680
Date:24.02.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 30.10.2008 takes the place of the publication of the European patent application.
[2010/08]
Type: B1 Patent specification 
No.:EP2155680
Date:04.12.2013
Language:EN
[2013/49]
Search report(s)International search report - published on:EP30.10.2008
ClassificationIPC:C07D213/16, C07D309/04, C07D333/10, C07C15/24, C07C235/04, A61K31/44, A61K31/381
[2010/08]
CPC:
C07D213/16 (EP,US); C07D213/56 (EP,US); C07D309/04 (EP,US);
C07D309/06 (EP,US); C07D333/10 (EP,US); C07D333/24 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/08]
Extension statesAL11.11.2009
BA11.11.2009
MK11.11.2009
RS11.11.2009
TitleGerman:PROLYLHYDROXYLASE HEMMENDE INDANONDERIVATE[2010/08]
English:INDANONE DERIVATIVES THAT INHIBIT PROLYL HYDROXYLASE[2010/08]
French:DÉRIVÉS D'INDANONE QUI INHIBENT LA PROLYLE HYDROXYLASE[2010/08]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase11.11.2009National basic fee paid 
11.11.2009Designation fee(s) paid 
11.11.2009Examination fee paid 
Examination procedure11.11.2009Amendment by applicant (claims and/or description)
11.11.2009Examination requested  [2010/08]
25.05.2010Despatch of a communication from the examining division (Time limit: M04)
02.07.2010Reply to a communication from the examining division
30.09.2010Despatch of a communication from the examining division (Time limit: M04)
13.01.2011Reply to a communication from the examining division
08.03.2013Despatch of a communication from the examining division (Time limit: M04)
09.04.2013Reply to a communication from the examining division
24.06.2013Communication of intention to grant the patent
22.10.2013Fee for grant paid
22.10.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.05.2010
Opposition(s)05.09.2014No opposition filed within time limit [2014/46]
Fees paidRenewal fee
25.03.2010Renewal fee patent year 03
12.04.2011Renewal fee patent year 04
28.03.2012Renewal fee patent year 05
12.04.2013Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU09.04.2008
AT04.12.2013
BE04.12.2013
BG04.12.2013
CY04.12.2013
CZ04.12.2013
DK04.12.2013
EE04.12.2013
FI04.12.2013
HR04.12.2013
LT04.12.2013
LV04.12.2013
MC04.12.2013
MT04.12.2013
NL04.12.2013
PL04.12.2013
RO04.12.2013
SE04.12.2013
SI04.12.2013
SK04.12.2013
TR04.12.2013
NO04.03.2014
GR05.03.2014
IS04.04.2014
PT04.04.2014
IE09.04.2014
LU09.04.2014
[2016/33]
Former [2016/32]HU09.04.2008
AT04.12.2013
BE04.12.2013
BG04.12.2013
CY04.12.2013
CZ04.12.2013
DK04.12.2013
EE04.12.2013
FI04.12.2013
HR04.12.2013
LT04.12.2013
LV04.12.2013
MC04.12.2013
MT04.12.2013
NL04.12.2013
PL04.12.2013
RO04.12.2013
SE04.12.2013
SI04.12.2013
SK04.12.2013
NO04.03.2014
GR05.03.2014
IS04.04.2014
PT04.04.2014
IE09.04.2014
LU09.04.2014
Former [2016/28]AT04.12.2013
BE04.12.2013
BG04.12.2013
CY04.12.2013
CZ04.12.2013
DK04.12.2013
EE04.12.2013
FI04.12.2013
HR04.12.2013
LT04.12.2013
LV04.12.2013
MC04.12.2013
MT04.12.2013
NL04.12.2013
PL04.12.2013
RO04.12.2013
SE04.12.2013
SI04.12.2013
SK04.12.2013
NO04.03.2014
GR05.03.2014
IS04.04.2014
PT04.04.2014
IE09.04.2014
LU09.04.2014
Former [2016/25]AT04.12.2013
BE04.12.2013
BG04.12.2013
CY04.12.2013
CZ04.12.2013
DK04.12.2013
EE04.12.2013
FI04.12.2013
HR04.12.2013
LT04.12.2013
LV04.12.2013
MC04.12.2013
MT04.12.2013
NL04.12.2013
PL04.12.2013
RO04.12.2013
SE04.12.2013
SI04.12.2013
SK04.12.2013
NO04.03.2014
IS04.04.2014
PT04.04.2014
IE09.04.2014
LU09.04.2014
Former [2016/16]AT04.12.2013
BE04.12.2013
CY04.12.2013
CZ04.12.2013
DK04.12.2013
EE04.12.2013
FI04.12.2013
HR04.12.2013
LT04.12.2013
LV04.12.2013
MC04.12.2013
MT04.12.2013
NL04.12.2013
PL04.12.2013
RO04.12.2013
SE04.12.2013
SI04.12.2013
SK04.12.2013
NO04.03.2014
IS04.04.2014
PT04.04.2014
IE09.04.2014
LU09.04.2014
Former [2015/21]AT04.12.2013
BE04.12.2013
CY04.12.2013
CZ04.12.2013
DK04.12.2013
EE04.12.2013
FI04.12.2013
HR04.12.2013
LT04.12.2013
LV04.12.2013
MC04.12.2013
NL04.12.2013
PL04.12.2013
RO04.12.2013
SE04.12.2013
SI04.12.2013
SK04.12.2013
NO04.03.2014
IS04.04.2014
PT04.04.2014
IE09.04.2014
LU09.04.2014
Former [2015/14]AT04.12.2013
BE04.12.2013
CY04.12.2013
CZ04.12.2013
DK04.12.2013
EE04.12.2013
FI04.12.2013
HR04.12.2013
LT04.12.2013
LV04.12.2013
MC04.12.2013
NL04.12.2013
PL04.12.2013
RO04.12.2013
SE04.12.2013
SI04.12.2013
SK04.12.2013
NO04.03.2014
IS04.04.2014
PT04.04.2014
LU09.04.2014
Former [2015/01]AT04.12.2013
BE04.12.2013
CY04.12.2013
CZ04.12.2013
DK04.12.2013
EE04.12.2013
FI04.12.2013
HR04.12.2013
LT04.12.2013
LV04.12.2013
MC04.12.2013
NL04.12.2013
PL04.12.2013
RO04.12.2013
SE04.12.2013
SK04.12.2013
NO04.03.2014
IS04.04.2014
PT04.04.2014
LU09.04.2014
Former [2014/52]AT04.12.2013
BE04.12.2013
CY04.12.2013
CZ04.12.2013
DK04.12.2013
EE04.12.2013
FI04.12.2013
HR04.12.2013
LT04.12.2013
LV04.12.2013
MC04.12.2013
NL04.12.2013
PL04.12.2013
RO04.12.2013
SE04.12.2013
SK04.12.2013
NO04.03.2014
IS04.04.2014
PT04.04.2014
Former [2014/48]AT04.12.2013
BE04.12.2013
CY04.12.2013
CZ04.12.2013
DK04.12.2013
EE04.12.2013
FI04.12.2013
HR04.12.2013
LT04.12.2013
LV04.12.2013
NL04.12.2013
PL04.12.2013
RO04.12.2013
SE04.12.2013
SK04.12.2013
NO04.03.2014
IS04.04.2014
PT04.04.2014
Former [2014/37]AT04.12.2013
BE04.12.2013
CY04.12.2013
CZ04.12.2013
EE04.12.2013
FI04.12.2013
HR04.12.2013
LT04.12.2013
LV04.12.2013
NL04.12.2013
PL04.12.2013
RO04.12.2013
SE04.12.2013
SK04.12.2013
NO04.03.2014
IS04.04.2014
PT04.04.2014
Former [2014/36]AT04.12.2013
BE04.12.2013
CY04.12.2013
EE04.12.2013
FI04.12.2013
HR04.12.2013
LT04.12.2013
LV04.12.2013
NL04.12.2013
SE04.12.2013
NO04.03.2014
IS04.04.2014
Former [2014/34]AT04.12.2013
BE04.12.2013
CY04.12.2013
FI04.12.2013
HR04.12.2013
LT04.12.2013
LV04.12.2013
NL04.12.2013
SE04.12.2013
NO04.03.2014
Former [2014/26]AT04.12.2013
CY04.12.2013
FI04.12.2013
HR04.12.2013
LT04.12.2013
LV04.12.2013
NL04.12.2013
SE04.12.2013
NO04.03.2014
Former [2014/25]AT04.12.2013
FI04.12.2013
HR04.12.2013
LT04.12.2013
LV04.12.2013
NL04.12.2013
SE04.12.2013
NO04.03.2014
Former [2014/24]AT04.12.2013
FI04.12.2013
HR04.12.2013
LT04.12.2013
NL04.12.2013
SE04.12.2013
NO04.03.2014
Former [2014/23]FI04.12.2013
HR04.12.2013
LT04.12.2013
NL04.12.2013
SE04.12.2013
NO04.03.2014
Former [2014/22]FI04.12.2013
LT04.12.2013
NL04.12.2013
SE04.12.2013
NO04.03.2014
Former [2014/20]LT04.12.2013
NO04.03.2014
Cited inInternational search[A]US5620995  (WEIDMANN KLAUS [DE], et al) [A] 1-31 * column 1, lines 1-28 * * claim 1 *;
 [A]US5719164  (WEIDMANN KLAUS [DE], et al) [A] 1-31 * column 1, lines 1-32 * * claim 1 *;
 [A]WO03053997  (FIBROGEN INC [US], et al) [A] 1-31 * paragraph [0019] * * claim 1 *;
 [A]WO2004108681  (FIBROGEN INC [US], et al) [A] 1-31;
 [A]  - FRANKLIN T J ET AL, "APPROACHES TO THE DESIGN OF ANTI-FIBROTIC DRUGS", BRAUNKOHLE, VERLAG DIE BRAUNKOHLE. DUSSELDORF, DE, (19910101), vol. 19, ISSN 0341-1060, pages 812 - 815, XP002022664 [A] 1-31 * page 813; table I *
by applicantUS5620995
 US5719164
 WO03053997
 WO2004108681
    - FRANKLIN ET AL., BIOCHEMICAL SOCIETY TRANSACTIONS, (1991), vol. 19, no. 4, pages 812 - 815
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.